Contact this trialFirst, we need to learn more about you.
Enzyme Inhibitor
BAY 1895344 + Radiation + Pembrolizumab for Head and Neck Cancer
Recruiting1 awardPhase 1
Oklahoma City, Oklahoma
This trial is testing a combination of drugs to see if they are effective in treating head and neck squamous cell cancer that has come back and cannot be removed through surgery. The drugs being tested are BAY 1895344, stereotactic body radiation therapy, and pembrolizumab. This combination of drugs may help to shrink or stabilize the cancer for a longer period of time than treatment with radiation and immunotherapy without BAY 1895344.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service